CBRS crashed 40% from its May high after Q2 missed estimates, yet 10 of 11 analysts still rate it Buy with a consensus target implying 57% upside.
NVDA fell just 7% and AMD dropped 10% over the same stretch, confirming CBRS’s brutal selloff was company-specific, not a sector-wide retreat.
A $25 billion backlog anchored by a $20 billion OpenAI deal and plans to triple 2027 revenue form the backbone of the bull case.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Cerebras Systems Inc. Class A Common Stock didn’t make the cut. Grab the names FREE today.
Cerebras Systems (NASDAQ:CBRS) currently trades near $185.43, while the average Wall Street price target sits at $291.64. That gap implies roughly 57% of upside to consensus.
24/7 Wall St.
Cerebras builds wafer-scale AI systems that sidestep the memory and packaging bottlenecks throttling standard GPU clusters. Its wafer-scale engine architecture avoids HBM memory, CoWoS packaging, and 3nm fabrication, and its customer roster runs through OpenAI, AWS, AMD, and CrowdStrike.
Wall Street expected explosive inference demand post-IPO. Instead, the stock has become one of the choppiest names in AI infrastructure, and that dislocation gives the price-to-target gap real teeth.
An IPO Darling Now Sitting Near Its Debut Price
Shares fell 26.41% in a single week after Q2 2026 results missed expectations. Revenue of $180.11 million fell short of the analyst estimate of $193.55 million, and GAAP EPS of -2.98 came in far below the consensus loss of -0.1801.
The bigger issue was margin guidance. Management guided Q3 core operating margin to negative 25% to negative 23%, down from negative 16% in Q2. On a widely read Reddit thread, traders summed up the reaction as “Cerebras falls 10% after chipmaker forecasts shrinking margin in first earnings report since IPO.”
Shares are now down 40.39% from a May high of $311.07. The move was company-specific. Semiconductors broadly held up over the same window.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Cerebras Systems Inc. Class A Common Stock didn’t make the cut. Grab the names FREE today.
UBS Sees 78% Upside From a $330 Street-High Target
Even with shares tumbling, analysts have barely blinked. UBS analyst Timothy Arcuri holds a $330 Street-high 12-month target, implying roughly 78% upside from current levels. His thesis rests on three pillars: the pending launch of Cerebras’s CS-4 wafer-scale platform with orders-of-magnitude higher SRAM memory bandwidth than GPU clusters, hyper-growth revenue anchored by enterprise and hyperscale backlog, and gross margin scaling into the 40%+ range as yields mature.
The backlog case is real. Remaining performance obligations sit at $25.4 billion, anchored by a multi-year OpenAI agreement for 750 megawatts of inference compute valued at more than $20 billion. Management raised full-year 2026 core revenue guidance to $880 to $890 million and plans to more than triple revenue in 2027.
CEO Andrew Feldman stated: “Fast tokens are in demand and command a premium at market.” He also flagged a disaggregated inference solution with AMD (NASDAQ:AMD) Helios deploying in Q4 and an AWS Bedrock rollout scheduled for Q1 2027, both viewed as catalysts for second-half re-rating.
Of the 11 analysts covering CBRS, 3 rate it Strong Buy, 7 Buy, and 1 Hold, with no Sells. Recent revisions have been reiterations rather than cuts.
How Cerebras Stacks Up Against NVIDIA and AMD
Cerebras fell alone. NVIDIA (NASDAQ:NVDA) and AMD, its two closest listed AI-compute peers, pulled back over the same stretch but nowhere near as violently.
NVIDIA sits at $208.48, down 7.35% on the week. Its consensus target of $304.73 implies about 46% upside, with analyst posture skewed heavily to Buys and revisions trending up on Blackwell demand.
AMD trades at $456.75 after slipping 9.73% last week. Its consensus target of $613.09 implies roughly 34% upside, backed by a Buy-heavy rating mix and recent target raises tied to the Instinct MI450 ramp.
The largest analyst-implied upside across the group sits with Cerebras. That says the Street thinks the selloff was overdone. It also says Cerebras carries the highest execution risk in the trio.
Where the Numbers Land
Cerebras currently trades at $185.43 against a consensus target of $291.64, with 11 covering analysts and 91% bullish sentiment. Analyst targets are not guarantees, but the skew here is unusually one-sided.
Recent performance shows the pain. CBRS is down 26.41% over the past week and 40.39% from its May peak. The S&P 500 is up 11.96% year to date and down just 1.19% on the week. That is idiosyncratic weakness on a scale the broader market simply is not showing.
Analyst ratings breakdown:
Strong Buy: 3
Buy: 7
Hold: 1
Sell: 0
Where I Come Down on Cerebras Here
The bull case rests on the CS-4 launch landing cleanly, the AWS Bedrock and AMD Helios integrations shipping on schedule, and management executing on tripling revenue in 2027. Q3 is guided as the low point for gross margins. If Q4 inflects as expected, the second-half re-rating alone gets the stock most of the way to consensus.
The bear case centers on the $377 million in stock-based compensation and concentration around OpenAI make the earnings picture uninvestable at this stage. If capacity ramp slips or a major customer renegotiates, the $291 target compresses fast.
I lean cautiously constructive. The $25.4 billion RPO figure and the AWS-AMD-OpenAI trifecta are too large to dismiss, and the risk/reward at $185 tilts toward the upside case. Size small and stomach volatility. This is not a table-pounder. (For readers hunting for the traits that showed up in early-stage AI compute winners before their runs, we cataloged them in a free playbook here.)
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Cerebras Systems Inc. Class A Common Stock didn’t make the cut. Grab the names FREE today.
